Nasri, 30, had appealed to UEFA for a therapeutic use exemption (TUE) following a multi-vitamin intravenous booster he received at a Los Angeles clinic in 2016.
That was rejected last March, as was an appeal in December to the Court of Arbitration for Sport.
However, he still has the right to appeal against his ban, UEFA said.
The method is on the World Anti-doping Agency's prohibited list and carries a maximum ban of four years.
The doping affair started when a Los Angeles clinic called Drip Doctors tweeted the fact they had treated Nasri with an intravenous vitamin booster whilst the player was on holiday there.
Nasri was at that time on loan from City at Sevilla, who expressed surprise when the story broke in the media -- Spanish anti-doping authorities quickly took up the matter and opened an inquiry at the end of 2016.
After shining as a youngster at his hometown club Marseille, Nasri was recruited by Arsene Wenger at Arsenal and switched three seasons later to City for a then sizeable 25 million (28m euros, $35m) transfer.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
